Document is current
Any future updates will be listed below
-
Authors
Franklin, Daniel http://orcid.org/0000-0002-6453-5114
Tzavelis, Andreas http://orcid.org/0000-0002-0750-5007
Lee, Jong Yoon
Chung, Ha Uk
Trueb, Jacob http://orcid.org/0000-0002-1627-5178
Arafa, Hany http://orcid.org/0000-0003-3191-8212
Kwak, Sung Soo
Huang, Ivy
Liu, Yiming
Rathod, Megh
Wu, Jonathan http://orcid.org/0009-0002-4786-786X
Liu, Haolin
Wu, Changsheng
Pandit, Jay A. http://orcid.org/0000-0003-0119-0881
Ahmad, Faraz S.
McCarthy, Patrick M.
Rogers, John A. http://orcid.org/0000-0002-2980-3961
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (F30HL157066, F30HL157066)
- License Information
-
More Information
Article History
Received: 11 March 2023
Accepted: 18 August 2023
First Online: 2 October 2023
Competing interests
: J.Y.L., H.U.C. and J.A.R. own equity in Sibel Health and hold patents (US20210361165A1, USA 2021 pending; US20210386300A1, USA 2021 pending; WO2023043866A1, WIPO 2023) associated with this company. The other authors declare no competing interests.
